Fig. A2.

Top row: Individual-specific evolutions for the conditional prevalence, by study site for children assumed to be symptomatic at the previous visit and were born in the baseline year (2001). Bottom row: Average evolutions for marginalized prevalence, by study site and the infection status at the previous visit and past use of AL (negative and no AL in the past (solid lines), negative and AL in the past (dotted lines), symptomatic (dash-dotted lines) and asymptomatic (long-dashed lines)). Left panel: Nagongera, middle panel: Kihihi, right panel: Walukuba.